dc.creator | Shevtsova E.F. | |
dc.creator | Vinogradova D.V. | |
dc.creator | Neganova M.E. | |
dc.creator | Avila-Rodriguez M. | |
dc.creator | Ashraf G.M. | |
dc.creator | Barreto G.E. | |
dc.creator | Bachurin S.O. | |
dc.creator | Aliev G. | |
dc.date.accessioned | 2020-09-02T22:28:14Z | |
dc.date.accessioned | 2022-11-08T20:24:49Z | |
dc.date.available | 2020-09-02T22:28:14Z | |
dc.date.available | 2022-11-08T20:24:49Z | |
dc.date.created | 2020-09-02T22:28:14Z | |
dc.date.issued | 2017 | |
dc.identifier | 16, 6, 677-685 | |
dc.identifier | 18715273 | |
dc.identifier | https://hdl.handle.net/20.500.12728/6251 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5145408 | |
dc.language | en | |
dc.publisher | Bentham Science Publishers B.V. | |
dc.subject | Alzheimer's disease | |
dc.subject | Mitochondria | |
dc.subject | Mitochondrial dysfunction | |
dc.subject | Multitarget benefits | |
dc.subject | Neurodegenerative diseases | |
dc.subject | Neuroprotective | |
dc.subject | alisporivir | |
dc.subject | amide | |
dc.subject | amyloid beta protein | |
dc.subject | azasteroid | |
dc.subject | cyclosporin A [4 n methylisoleucine] | |
dc.subject | dimebon | |
dc.subject | melatonin | |
dc.subject | mitochondrial permeability transition pore | |
dc.subject | n acetylserotonin | |
dc.subject | neuroprotective agent | |
dc.subject | pilocarpine | |
dc.subject | securinine | |
dc.subject | tryptamine | |
dc.subject | carrier protein | |
dc.subject | mitochondrial permeability transition pore | |
dc.subject | neuroprotective agent | |
dc.subject | Alzheimer disease | |
dc.subject | antidepressant activity | |
dc.subject | Article | |
dc.subject | calcium transport | |
dc.subject | cell function | |
dc.subject | cell organelle | |
dc.subject | cognition | |
dc.subject | human | |
dc.subject | immunosuppressive treatment | |
dc.subject | metabolic balance | |
dc.subject | mitochondrial membrane potential | |
dc.subject | molecular interaction | |
dc.subject | nerve degeneration | |
dc.subject | nerve stimulation | |
dc.subject | neurotransmission | |
dc.subject | nonhuman | |
dc.subject | oxidative stress | |
dc.subject | protein targeting | |
dc.subject | seizure | |
dc.subject | systematic review | |
dc.subject | Alzheimer disease | |
dc.subject | animal | |
dc.subject | drug effect | |
dc.subject | mitochondrion | |
dc.subject | physiology | |
dc.subject | Alzheimer Disease | |
dc.subject | Animals | |
dc.subject | Humans | |
dc.subject | Mitochondria | |
dc.subject | Mitochondrial Membrane Transport Proteins | |
dc.subject | Neuroprotective Agents | |
dc.title | Mitochondrial permeability transition pore as a suitable target for neuroprotective agents against alzheimer’s disease | |
dc.type | Article | |